Systemic lupus erythematosus: an expert insight into emerging therapy agents in preclinical and early clinical development

Repurposing prolactin as a promising immunomodulator for the treatment of COVID-19: Are common Antiemetics the wonder drug to fight coronavirus?

Human papillomavirus vaccine safety in systemic lupus erythematosus patients

Bisphenol A modified DNA: A possible immunogenic stimulus for anti-DNA autoantibodies in systemic lupus erythematosus

Impact of the COVID-19 outbreak on an Italian cohort of systemic sclerosis patients

Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine

Evolving Immunologic Perspectives in Chronic Inflammatory Demyelinating Polyneuropathy

Immune checkpoint inhibitors (ICI) have the potential to worsen pre-existing anti-Hu paraneoplastic neurologic syndrome (PNS).

Currently, there are few data on Antiphospholipid antibodies (aPL Ab) in COVID-19 and it is unclear if they represent an epiphenomenon or are involved in pathogenesis of COVID-19 disease.

Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome